Author: Martin P. Schrama
Loosening Pandemic Protocols Are Pointing to Progress in the Hernia Mesh Litigations
Posted in Medical Devices
As you know, COVID-19 has hit some sectors harder than others. The judiciary was especially susceptible because it relied on in-person proceedings – for example, you may have observed that no one in your family has received a jury duty notice lately. Though it is of little comfort to you,… Continue reading
Elmiron Litigation Continues: What they still aren’t telling you…
Posted in Defective Drugs, Elmiron
The Product – Elmiron Elmiron, also known as pentosan polysulfate sodium (PPS), is used to treat interstitial cystitis. Interstitial cystis is an ailment of the urinary tract system that may cause pain in the abdomen, pelvic and genital regions. Although Elmiron is not a cure to interstitial cystitis (IC), it… Continue reading
Left Behind by the #MeToo Movement: Female Prisoners
Posted in Business & Commercial Law
Garnering far less attention and, frankly, far less sympathy than the Hollywood and political headlines, there are the female victims trapped in the prison system. It has been over two years since a class action complaint was filed on behalf of thousands of potential female class members against the New… Continue reading
FDA Zantac Recall: Too Little, Too Late
Posted in Defective Drugs, Zantac
In the face of mounting nationwide lawsuits and continuing alarming testing data, the United States Food and Drug Administration (FDA) has finally announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. As a result of this immediate market withdrawal request, ranitidine products… Continue reading
A Simple Guide to Paragard Lawsuits and Settlements
Posted in Medical Devices
You have seen a lot of commercials and have probably been searching the internet for some straightforward explanations about Paragard. Here is a simple guide to Paragard lawsuits and settlements in four easy steps: Step 1: Get Your Medical Records Confirming Your IUD Implant. Step 2: Identify Your Paragard IUD… Continue reading
A Guide to Figuring Out What Your Defective Hernia Mesh Case is Worth
Posted in Medical Devices
So, what is my defective hernia mesh case worth? It is a very simple question, but you have done quite a bit of research and consulted with supposed experts – and no one can give you a straight answer. The answer is that no one knows specifically what your case… Continue reading
A Simple Guide to Zantac Cancer Lawsuits and Settlements
Posted in Defective Drugs, Zantac
How Do I Know If I Have a Zantac Cancer Claim? You have already done quite a bit of internet research and likely found that getting to the answer can be a little more complicated than it sounds. “Zantac” is just the brand name of a popular heartburn drug called… Continue reading
Bard Hernia Mesh Cases Leading the Charge to Settlements in Hernia Mesh Litigations
Posted in Medical Devices
The primary Bard Hernia Mesh state litigation, pending in Rhode Island state court under Judge Gibney, is now set to begin its first bellwether trials that will focus on claims involving the Ventralex patch product, and proceed to trials involving the Composix E/X product. Not to be outdone, and though… Continue reading
What is the Deal With Zantac Cancer Lawsuits and Settlements?
Posted in Defective Drugs, Zantac
What is Zantac (ranitidine)? You have seen a lot of commercials and have probably been searching the internet for some straightforward explanations about Zantac Cancer Lawsuits and Settlements. Very simply, Zantac is the brand name of a common heartburn medication called ranitidine. Zantac (ranitidine) is a type of drug known as… Continue reading
Zantac and Cancer: the Plot Thickens
Posted in Defective Drugs, Zantac
The potential issues with Zantac just became a little more complicated. Zantac is the brand name of a common heartburn medication called ranitidine. As we have reported, there have been multiple, and ongoing, recalls of ranitidine after testing of lots of the drug showed unacceptable levels of the probable human carcinogen… Continue reading
